Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Alphamab Oncology"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 187.13% vs 24.59% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 177.52% vs 38.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "694.00",
          "val2": "241.70",
          "chgp": "187.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "193.00",
          "val2": "-280.90",
          "chgp": "168.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.80",
          "val2": "13.50",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "180.40",
          "val2": "-232.70",
          "chgp": "177.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "157.80%",
          "val2": "-1,477.90%",
          "chgp": "163.57%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

694.00

241.70

187.13%

Operating Profit (PBDIT) excl Other Income

193.00

-280.90

168.71%

Interest

10.80

13.50

-20.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

180.40

-232.70

177.52%

Operating Profit Margin (Excl OI)

157.80%

-1,477.90%

163.57%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 187.13% vs 24.59% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 177.52% vs 38.57% in Dec 2023

All Annual Results